Treatment of herpes simplex virus infections.
Herpes simplex virus (HSV) types 1 and 2 are ubiquitous organisms that cause infections in human populations throughout the world. The clinical manifestations of HSV infections are varied, ranging from asymptomatic disease to life-threatening illness in neonates and immunocompromised hosts. This article will review the common presentations for HSV disease and the current recommendations for the treatment of these infections. A detailed summary of the antiviral drugs used to treat HSV infections is also presented.
Brady
Rebecca C
RC
Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, 3333 Burnet Avenue, Mail Location 6014, Cincinnati, OH 45229-3039, USA. rebecca.brady@cchmc.org
Bernstein
David I
DI
D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D006561:Herpes Simplex / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D018259:Herpesvirus 1, Human; D018258:Herpesvirus 2, Human; D006801:Humans; D016867:Immunocompromised Host; D007231:Infant, Newborn; D008297:Male; D014765:Viral Vaccines / Q000302:isolation & purification
D000998:Antiviral Agents; D014765:Viral Vaccines